newsfilter
← Latest News
GlobeNewswire·

Antares Pharma Announces Partner Idorsia Initiates the Phase 3 Study With Selatogrel for Acute Myocardial Infarction

EWING, N.J., June 28, 2021 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ:ATRS) ("the Company"), a specialty pharmaceutical company, today announced that its partner Idorsia Ltd ("Idorsia") initiated its Phase 3 registration study to evaluate the eff